ECZEMA

There are 10 studies

ECZEMA STUDY

Hot Springs

Study number: J2T-MC-KGAK/DRM06-AD18

NOW ENROLLING: the ADopt-VA study

With atopic dermatitis, itching isn't even the worst part.

From the embarrassing red blotches to the painful sores, atopic dermatitis symptoms require the right treatment. You may qualify to participate in the ADopt-VA study for an injectable investigational medication.

To be eligible for the ADopt-VA study, you must:
- Be between the ages of 18 and 55 years old
- Have had moderate-to-severe AD for at least one year, with a history of inadequate response to topical treatments
- Have not recently received the Tdap (tetanus, diptheria, and pertussis) or MCV (meningococcal) vaccines

This is not a complete list of study requirements. The study doctor will review all requirements with you.

Ask your doctor if you are eligible for this clinical research study.

To learn more about the ADopt-VA study, contact:
BURKE PHARMACEUTICAL RESEARCH

3633 Central Avenue, Ste I
Hot Springs, AR 71913

Learn More

ECZEMA STUDY

Houston

Hand & Foot Dermatitis Research Study

Center for Clinical Studies is looking for volunteers to participate in a new clinical research study testing an investigational medication for individuals diagnosed with moderate-to-severe chronic atopic hand and/or foot dermatitis.

Qualifications Include:
• Be age 12 or older
• Have chronic hand and/or foot dermatitis diagnosed at least 6 months prior to the screening visit
• Has had an Inadequate response to topical medication(s) or for whom topical treatments is medically inadvisable
• Meet additional study criteria

Have you been diagnosed with Atopic hand & foot dermatitis?
Want to learn about a new clinical trial?

Qualified participants will receive study-related care and medication at no cost. You may receive reimbursement for your time and travel. Health insurance is not needed.

Call
CCS

Center for Clinical Studies

Learn More

ECZEMA STUDY

Boston

Study number: J2T-MC-KGAK/DRM06-AD18

NOW ENROLLING: the ADopt-VA study

With atopic dermatitis, itching isn’t even the worst part.

From the embarrassing red blotches to the painful sores, atopic dermatitis symptoms require the right treatment. You may qualify to participate in the ADopt-VA study for an injectable investigational medication.

To be eligible for the ADopt-VA study, you must:
• Be between the ages of 18 and 55 years old
• Have had moderate-to-severe AD for at least one year, with a history of inadequate response to topical treatments
• Have not recently received the Tdap (tetanus, diphtheria, and pertussis) or MCV (meningococcal) vaccines

Ask your doctor if you are eligible for this clinical research study.

This is not a complete list of study requirements. The study doctor will review all requirements with you.

To learn more about the ADopt-VA study, contact:

Metro Boston Clinical Partners, LLC
280 Washington Street Ste #204, Brighton, Boston, MA 02135

ADopt-VA Study

Learn More

ECZEMA STUDY

Poway

Study number: J2T-MC-KGAK/DRM06-AD18

NOW ENROLLING: the ADopt-VA study

With atopic dermatitis, itching isn’t even the worst part.

From the embarrassing red blotches to the painful sores, atopic dermatitis symptoms require the right treatment. You may qualify to participate in the ADopt-VA study for an injectable investigational medication.

To be eligible for the ADopt-VA study, you must:
• Be between the ages of 18 and 55 years old
• Have had moderate-to-severe AD for at least one year, with a history of inadequate response to topical treatments
• Have not recently received the Tdap (tetanus, diphtheria, and pertussis) or MCV (meningococcal) vaccines

This is not a complete list of study requirements. The study doctor will review all requirements with you.

To learn more about the ADopt-VA study, contact:

Ask your doctor if you are eligible for this clinical research study.

Contact us today!

acrc STUDIES
15725 Pomerado Rd Suite 108, Poway, CA 92064

This study is funded by Eli Lilly & Company

Learn More